[20190621]IF10391_大麻衍生大麻二酚(CBD)及相关大麻提取物.pdf

上传人:任我行 文档编号:28300 上传时间:2022-06-24 发布时间:2019-06-21 格式:PDF 页数:3 大小:448.53KB
下载 相关 举报
[20190621]IF10391_大麻衍生大麻二酚(CBD)及相关大麻提取物.pdf_第1页
第1页 / 共3页
[20190621]IF10391_大麻衍生大麻二酚(CBD)及相关大麻提取物.pdf_第2页
第2页 / 共3页
[20190621]IF10391_大麻衍生大麻二酚(CBD)及相关大麻提取物.pdf_第3页
第3页 / 共3页
亲,该文档总共3页,全部预览完了,如果喜欢就下载吧!
资源描述

1、 https:/crsreports.congress.gov Updated June 21, 2019Hemp-Derived Cannabidiol (CBD) and Related Hemp ExtractsCannabidiol (CBD) is a plant-derived compound from Cannabis sativa, the species of plant that includes both hemp and marijuana, but from different plant varieties or cultivars. CBD is the pri

2、mary nonpsychoactive compound in cannabis, whereas tetrahydrocannabinol (THC) is cannabiss primary psychoactive compound. CBD is promoted as treatment for a range of conditionsincluding epileptic seizures, post-traumatic stress disorder, anxiety, and inflammationdespite limited scientific evidence t

3、o substantiate many of these claims. In the United States, CBD is marketed in a range of consumer productsfood and beverages, dietary supplements, personal care products, and cosmeticssubject to regulation by the Food and Drug Administration (FDA). Consumer products containing plant-based CBD are ei

4、ther hemp- or marijuana-derived. Market for Hemp-Derived CBD The 2018 farm bill (Agriculture Improvement Act of 2018, P.L. 115-334) included a number of provisions intended to facilitate the commercial cultivation, processing, marketing, and sale of hemp in the United States, expanding on policies e

展开阅读全文
相关资源
猜你喜欢
相关搜索
资源标签

当前位置:首页 > 法规条令 > CRS 美国国会研究处报告